Koss Corp (KOSS) CFO awarded 50,000 stock options at $4.30

Rhea-AI Filing Summary

Koss Corp Chief Financial Officer Kim M. Schulte reported a compensation-related award of stock options. She received 50,000 stock options to buy Koss common stock at an exercise price of $4.30 per share, expiring on May 6, 2036. These options vest in five equal annual installments beginning on May 6, 2027, meaning the award becomes exercisable gradually over five years. Following this grant, she holds 50,000 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schulte Kim M.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to Buy)	50,000	$0.00	--

Holdings After Transaction: Stock Options (Right to Buy) — 50,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 50,000 options Exercise price: $4.30 per share Expiration date: May 6, 2036 +2 more

5 metrics

Options granted 50,000 options Stock options award to CFO Kim M. Schulte

Exercise price $4.30 per share Stock option strike price

Expiration date May 6, 2036 Option term end date

Vesting schedule 5 equal annual installments Begins May 6, 2027

Options held after grant 50,000 options Total derivative holdings following transaction

Key Terms

Stock Options (Right to Buy), exercise price, expiration date, Common Stock, +1 more

5 terms

Stock Options (Right to Buy) financial

"security_title: "Stock Options (Right to Buy)""

exercise price financial

"conversion_or_exercise_price: "4.3000""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2036-05-06T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schulte Kim M.

(Last) (First) (Middle)

KOSS CORPORATION

4129 N. PORT WASHINGTON AVE.

(Street)

MILWAUKEE WISCONSIN 53212

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KOSS CORP [ KOSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$4.3	05/06/2026		A		50,000		(1)	05/06/2036	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. These Stock Options vest in five equal annual installments beginning on May 6, 2027.

	/s/ Kim M. Schulte	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did KOSS CFO Kim M. Schulte report on this Form 4?

Kim M. Schulte reported receiving a grant of 50,000 stock options. The options give her the right to buy Koss common stock at $4.30 per share and represent a compensation award rather than an open-market purchase or sale.

What are the key terms of the KOSS CFO’s 50,000 stock option grant?

The CFO’s grant covers 50,000 stock options with a $4.30 exercise price. The options expire on May 6, 2036, giving a long exercise window, and are tied to Koss common stock as the underlying security.

How do the KOSS CFO’s new stock options vest over time?

The 50,000 stock options vest in five equal annual installments beginning May 6, 2027. Each year, one-fifth of the grant becomes exercisable, gradually increasing the CFO’s ability to purchase shares over a five-year period.

Did the KOSS CFO buy or sell common shares in this Form 4 filing?

No common shares were bought or sold in this filing. The transaction reflects a grant of stock options as compensation, giving future rights to acquire Koss common stock rather than an immediate market transaction.

How many KOSS stock options does the CFO hold after this reported grant?

After this transaction, the Form 4 shows the CFO directly holding 50,000 stock options. These options all relate to the new grant reported and are subject to the stated vesting schedule and the $4.30 exercise price.